{"id":"NCT00406640","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women","officialTitle":"A Multicenter, Randomized, 8-Week Double-Blind Acute Phase Followed By a 6-Month Continuation Phase (Open-Label Or Double-Blind) Study to Evaluate the Efficacy, Safety, and Tolerability of DVS SR Versus Escitalopram in Postmenopausal Women With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2008-02","completion":"2008-10","firstPosted":"2006-12-04","resultsPosted":"2010-06-29","lastUpdate":"2023-12-28"},"enrollment":595,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Depression","Depressive Disorder","Depressive Disorder, Major"],"interventions":[{"type":"DRUG","name":"Desvenlafaxine succinate sustained-release (DVS SR)","otherNames":[]},{"type":"DRUG","name":"Escitalopram","otherNames":[]}],"arms":[{"label":"A","type":"ACTIVE_COMPARATOR"},{"label":"B","type":"ACTIVE_COMPARATOR"}],"summary":"Desvenlafaxine succinate (DVS) is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI). This study will investigate the safety, efficacy, and tolerability of DVS SR versus escitalopram in women with major depressive disorder (MDD) who are postmenopausal.","primaryOutcome":{"measure":"Change in Hamilton Psychiatric Rating Scale for Depression (HAM-D17) Score From Baseline to Week 8","timeFrame":"Baseline and 8 weeks","effectByArm":[{"arm":"Desvenlafaxine Succinate Sustained-release (DVS SR)","deltaMin":-13.63,"sd":0.42},{"arm":"Escitalopram","deltaMin":-14.3,"sd":0.4}],"pValues":[{"comp":"OG000 vs OG001","p":"0.243"}]},"eligibility":{"minAge":"40 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":70,"countries":["United States","Argentina","Chile","Colombia","Mexico","Peru"]},"refs":{"pmids":["21323394"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5},"commonTop":["Headache","Dry mouth","Nausea","Sommolence","Constipation"]}}